Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target
A search of broader range of chemical space is important for drug discovery. Different methods of computer-aided drug discovery (CADD) are known to propose compounds in different chemical spaces as hit molecules for the same target protein. This study aimed at using multiple CADD methods through ope...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2015-11, Vol.5 (1), p.17209-17209, Article 17209 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 17209 |
---|---|
container_issue | 1 |
container_start_page | 17209 |
container_title | Scientific reports |
container_volume | 5 |
creator | Chiba, Shuntaro Ikeda, Kazuyoshi Ishida, Takashi Gromiha, M. Michael Taguchi, Y-h. Iwadate, Mitsuo Umeyama, Hideaki Hsin, Kun-Yi Kitano, Hiroaki Yamamoto, Kazuki Sugaya, Nobuyoshi Kato, Koya Okuno, Tatsuya Chikenji, George Mochizuki, Masahiro Yasuo, Nobuaki Yoshino, Ryunosuke Yanagisawa, Keisuke Ban, Tomohiro Teramoto, Reiji Ramakrishnan, Chandrasekaran Thangakani, A. Mary Velmurugan, D. Prathipati, Philip Ito, Junichi Tsuchiya, Yuko Mizuguchi, Kenji Honma, Teruki Hirokawa, Takatsugu Akiyama, Yutaka Sekijima, Masakazu |
description | A search of broader range of chemical space is important for drug discovery. Different methods of computer-aided drug discovery (CADD) are known to propose compounds in different chemical spaces as hit molecules for the same target protein. This study aimed at using multiple CADD methods through open innovation to achieve a level of hit molecule diversity that is not achievable with any particular single method. We held a compound proposal contest, in which multiple research groups participated and predicted inhibitors of tyrosine-protein kinase Yes. This showed whether collective knowledge based on individual approaches helped to obtain hit compounds from a broad range of chemical space and whether the contest-based approach was effective. |
doi_str_mv | 10.1038/srep17209 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4660442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1738482024</sourcerecordid><originalsourceid>FETCH-LOGICAL-c520t-87d1050af403a4c4dbf9f27ef06b32652e4f0f02e676608f27c4b326635a8d023</originalsourceid><addsrcrecordid>eNptkUtLAzEUhYMotqgL_4BkqcJoJpN5uRCk-CgIbnThKmQySZs6TcYkI_Tfe0trUTAEEnK-nOTeg9BpSq5SklXXwas-LSmp99CYEpYnNKN0_9d-hE5CWBAYOa1ZWh-iES0KUtI6GyM_bZWNRhsponEWO417F9dHosPGzk1jovMBNyKoFgMg3bJ3g21x713vAlDS2ahCvMGvK--CsSoBKSpj8YexcA2_q4AFTByFn6l4jA606II62a5H6O3h_nXylDy_PE4nd8-JzCmJSVW2KcmJ0IxkgknWNrrWtFSaFE1Gi5wqpokmVBUlVFOBJNlaKLJcVC2h2RG63fj2Q7NUrYSivOh4781S-BV3wvC_ijVzPnNfnIEfY2uD862Bd58DlMiXJkjVdcIqNwSellnFKkooA_Rig0poASSid8-khK9j4ruYgD37_a8d-RMKAJcbIIBkZ8rzhRu8hV794_YNbwyenw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1738482024</pqid></control><display><type>article</type><title>Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target</title><source>PubMed (Medline)</source><source>MEDLINE</source><source>Nature Free</source><source>DOAJ Directory of Open Access Journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><source>EZB Electronic Journals Library</source><source>Springer Nature OA Free Journals</source><creator>Chiba, Shuntaro ; Ikeda, Kazuyoshi ; Ishida, Takashi ; Gromiha, M. Michael ; Taguchi, Y-h. ; Iwadate, Mitsuo ; Umeyama, Hideaki ; Hsin, Kun-Yi ; Kitano, Hiroaki ; Yamamoto, Kazuki ; Sugaya, Nobuyoshi ; Kato, Koya ; Okuno, Tatsuya ; Chikenji, George ; Mochizuki, Masahiro ; Yasuo, Nobuaki ; Yoshino, Ryunosuke ; Yanagisawa, Keisuke ; Ban, Tomohiro ; Teramoto, Reiji ; Ramakrishnan, Chandrasekaran ; Thangakani, A. Mary ; Velmurugan, D. ; Prathipati, Philip ; Ito, Junichi ; Tsuchiya, Yuko ; Mizuguchi, Kenji ; Honma, Teruki ; Hirokawa, Takatsugu ; Akiyama, Yutaka ; Sekijima, Masakazu</creator><creatorcontrib>Chiba, Shuntaro ; Ikeda, Kazuyoshi ; Ishida, Takashi ; Gromiha, M. Michael ; Taguchi, Y-h. ; Iwadate, Mitsuo ; Umeyama, Hideaki ; Hsin, Kun-Yi ; Kitano, Hiroaki ; Yamamoto, Kazuki ; Sugaya, Nobuyoshi ; Kato, Koya ; Okuno, Tatsuya ; Chikenji, George ; Mochizuki, Masahiro ; Yasuo, Nobuaki ; Yoshino, Ryunosuke ; Yanagisawa, Keisuke ; Ban, Tomohiro ; Teramoto, Reiji ; Ramakrishnan, Chandrasekaran ; Thangakani, A. Mary ; Velmurugan, D. ; Prathipati, Philip ; Ito, Junichi ; Tsuchiya, Yuko ; Mizuguchi, Kenji ; Honma, Teruki ; Hirokawa, Takatsugu ; Akiyama, Yutaka ; Sekijima, Masakazu</creatorcontrib><description>A search of broader range of chemical space is important for drug discovery. Different methods of computer-aided drug discovery (CADD) are known to propose compounds in different chemical spaces as hit molecules for the same target protein. This study aimed at using multiple CADD methods through open innovation to achieve a level of hit molecule diversity that is not achievable with any particular single method. We held a compound proposal contest, in which multiple research groups participated and predicted inhibitors of tyrosine-protein kinase Yes. This showed whether collective knowledge based on individual approaches helped to obtain hit compounds from a broad range of chemical space and whether the contest-based approach was effective.</description><identifier>ISSN: 2045-2322</identifier><identifier>EISSN: 2045-2322</identifier><identifier>DOI: 10.1038/srep17209</identifier><identifier>PMID: 26607293</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/114/2248 ; 631/154/1435/2418 ; Drug Evaluation, Preclinical ; Humanities and Social Sciences ; Humans ; multidisciplinary ; Principal Component Analysis ; Protein Kinase Inhibitors - analysis ; Protein Kinase Inhibitors - pharmacology ; Proto-Oncogene Proteins c-yes - antagonists & inhibitors ; Proto-Oncogene Proteins c-yes - chemistry ; Reproducibility of Results ; Science ; src-Family Kinases - metabolism</subject><ispartof>Scientific reports, 2015-11, Vol.5 (1), p.17209-17209, Article 17209</ispartof><rights>The Author(s) 2015</rights><rights>Copyright © 2015, Macmillan Publishers Limited 2015 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c520t-87d1050af403a4c4dbf9f27ef06b32652e4f0f02e676608f27c4b326635a8d023</citedby><cites>FETCH-LOGICAL-c520t-87d1050af403a4c4dbf9f27ef06b32652e4f0f02e676608f27c4b326635a8d023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660442/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660442/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,41096,42165,51551,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26607293$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chiba, Shuntaro</creatorcontrib><creatorcontrib>Ikeda, Kazuyoshi</creatorcontrib><creatorcontrib>Ishida, Takashi</creatorcontrib><creatorcontrib>Gromiha, M. Michael</creatorcontrib><creatorcontrib>Taguchi, Y-h.</creatorcontrib><creatorcontrib>Iwadate, Mitsuo</creatorcontrib><creatorcontrib>Umeyama, Hideaki</creatorcontrib><creatorcontrib>Hsin, Kun-Yi</creatorcontrib><creatorcontrib>Kitano, Hiroaki</creatorcontrib><creatorcontrib>Yamamoto, Kazuki</creatorcontrib><creatorcontrib>Sugaya, Nobuyoshi</creatorcontrib><creatorcontrib>Kato, Koya</creatorcontrib><creatorcontrib>Okuno, Tatsuya</creatorcontrib><creatorcontrib>Chikenji, George</creatorcontrib><creatorcontrib>Mochizuki, Masahiro</creatorcontrib><creatorcontrib>Yasuo, Nobuaki</creatorcontrib><creatorcontrib>Yoshino, Ryunosuke</creatorcontrib><creatorcontrib>Yanagisawa, Keisuke</creatorcontrib><creatorcontrib>Ban, Tomohiro</creatorcontrib><creatorcontrib>Teramoto, Reiji</creatorcontrib><creatorcontrib>Ramakrishnan, Chandrasekaran</creatorcontrib><creatorcontrib>Thangakani, A. Mary</creatorcontrib><creatorcontrib>Velmurugan, D.</creatorcontrib><creatorcontrib>Prathipati, Philip</creatorcontrib><creatorcontrib>Ito, Junichi</creatorcontrib><creatorcontrib>Tsuchiya, Yuko</creatorcontrib><creatorcontrib>Mizuguchi, Kenji</creatorcontrib><creatorcontrib>Honma, Teruki</creatorcontrib><creatorcontrib>Hirokawa, Takatsugu</creatorcontrib><creatorcontrib>Akiyama, Yutaka</creatorcontrib><creatorcontrib>Sekijima, Masakazu</creatorcontrib><title>Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target</title><title>Scientific reports</title><addtitle>Sci Rep</addtitle><addtitle>Sci Rep</addtitle><description>A search of broader range of chemical space is important for drug discovery. Different methods of computer-aided drug discovery (CADD) are known to propose compounds in different chemical spaces as hit molecules for the same target protein. This study aimed at using multiple CADD methods through open innovation to achieve a level of hit molecule diversity that is not achievable with any particular single method. We held a compound proposal contest, in which multiple research groups participated and predicted inhibitors of tyrosine-protein kinase Yes. This showed whether collective knowledge based on individual approaches helped to obtain hit compounds from a broad range of chemical space and whether the contest-based approach was effective.</description><subject>631/114/2248</subject><subject>631/154/1435/2418</subject><subject>Drug Evaluation, Preclinical</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>multidisciplinary</subject><subject>Principal Component Analysis</subject><subject>Protein Kinase Inhibitors - analysis</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Proto-Oncogene Proteins c-yes - antagonists & inhibitors</subject><subject>Proto-Oncogene Proteins c-yes - chemistry</subject><subject>Reproducibility of Results</subject><subject>Science</subject><subject>src-Family Kinases - metabolism</subject><issn>2045-2322</issn><issn>2045-2322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNptkUtLAzEUhYMotqgL_4BkqcJoJpN5uRCk-CgIbnThKmQySZs6TcYkI_Tfe0trUTAEEnK-nOTeg9BpSq5SklXXwas-LSmp99CYEpYnNKN0_9d-hE5CWBAYOa1ZWh-iES0KUtI6GyM_bZWNRhsponEWO417F9dHosPGzk1jovMBNyKoFgMg3bJ3g21x713vAlDS2ahCvMGvK--CsSoBKSpj8YexcA2_q4AFTByFn6l4jA606II62a5H6O3h_nXylDy_PE4nd8-JzCmJSVW2KcmJ0IxkgknWNrrWtFSaFE1Gi5wqpokmVBUlVFOBJNlaKLJcVC2h2RG63fj2Q7NUrYSivOh4781S-BV3wvC_ijVzPnNfnIEfY2uD862Bd58DlMiXJkjVdcIqNwSellnFKkooA_Rig0poASSid8-khK9j4ruYgD37_a8d-RMKAJcbIIBkZ8rzhRu8hV794_YNbwyenw</recordid><startdate>20151126</startdate><enddate>20151126</enddate><creator>Chiba, Shuntaro</creator><creator>Ikeda, Kazuyoshi</creator><creator>Ishida, Takashi</creator><creator>Gromiha, M. Michael</creator><creator>Taguchi, Y-h.</creator><creator>Iwadate, Mitsuo</creator><creator>Umeyama, Hideaki</creator><creator>Hsin, Kun-Yi</creator><creator>Kitano, Hiroaki</creator><creator>Yamamoto, Kazuki</creator><creator>Sugaya, Nobuyoshi</creator><creator>Kato, Koya</creator><creator>Okuno, Tatsuya</creator><creator>Chikenji, George</creator><creator>Mochizuki, Masahiro</creator><creator>Yasuo, Nobuaki</creator><creator>Yoshino, Ryunosuke</creator><creator>Yanagisawa, Keisuke</creator><creator>Ban, Tomohiro</creator><creator>Teramoto, Reiji</creator><creator>Ramakrishnan, Chandrasekaran</creator><creator>Thangakani, A. Mary</creator><creator>Velmurugan, D.</creator><creator>Prathipati, Philip</creator><creator>Ito, Junichi</creator><creator>Tsuchiya, Yuko</creator><creator>Mizuguchi, Kenji</creator><creator>Honma, Teruki</creator><creator>Hirokawa, Takatsugu</creator><creator>Akiyama, Yutaka</creator><creator>Sekijima, Masakazu</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20151126</creationdate><title>Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target</title><author>Chiba, Shuntaro ; Ikeda, Kazuyoshi ; Ishida, Takashi ; Gromiha, M. Michael ; Taguchi, Y-h. ; Iwadate, Mitsuo ; Umeyama, Hideaki ; Hsin, Kun-Yi ; Kitano, Hiroaki ; Yamamoto, Kazuki ; Sugaya, Nobuyoshi ; Kato, Koya ; Okuno, Tatsuya ; Chikenji, George ; Mochizuki, Masahiro ; Yasuo, Nobuaki ; Yoshino, Ryunosuke ; Yanagisawa, Keisuke ; Ban, Tomohiro ; Teramoto, Reiji ; Ramakrishnan, Chandrasekaran ; Thangakani, A. Mary ; Velmurugan, D. ; Prathipati, Philip ; Ito, Junichi ; Tsuchiya, Yuko ; Mizuguchi, Kenji ; Honma, Teruki ; Hirokawa, Takatsugu ; Akiyama, Yutaka ; Sekijima, Masakazu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c520t-87d1050af403a4c4dbf9f27ef06b32652e4f0f02e676608f27c4b326635a8d023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>631/114/2248</topic><topic>631/154/1435/2418</topic><topic>Drug Evaluation, Preclinical</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>multidisciplinary</topic><topic>Principal Component Analysis</topic><topic>Protein Kinase Inhibitors - analysis</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Proto-Oncogene Proteins c-yes - antagonists & inhibitors</topic><topic>Proto-Oncogene Proteins c-yes - chemistry</topic><topic>Reproducibility of Results</topic><topic>Science</topic><topic>src-Family Kinases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chiba, Shuntaro</creatorcontrib><creatorcontrib>Ikeda, Kazuyoshi</creatorcontrib><creatorcontrib>Ishida, Takashi</creatorcontrib><creatorcontrib>Gromiha, M. Michael</creatorcontrib><creatorcontrib>Taguchi, Y-h.</creatorcontrib><creatorcontrib>Iwadate, Mitsuo</creatorcontrib><creatorcontrib>Umeyama, Hideaki</creatorcontrib><creatorcontrib>Hsin, Kun-Yi</creatorcontrib><creatorcontrib>Kitano, Hiroaki</creatorcontrib><creatorcontrib>Yamamoto, Kazuki</creatorcontrib><creatorcontrib>Sugaya, Nobuyoshi</creatorcontrib><creatorcontrib>Kato, Koya</creatorcontrib><creatorcontrib>Okuno, Tatsuya</creatorcontrib><creatorcontrib>Chikenji, George</creatorcontrib><creatorcontrib>Mochizuki, Masahiro</creatorcontrib><creatorcontrib>Yasuo, Nobuaki</creatorcontrib><creatorcontrib>Yoshino, Ryunosuke</creatorcontrib><creatorcontrib>Yanagisawa, Keisuke</creatorcontrib><creatorcontrib>Ban, Tomohiro</creatorcontrib><creatorcontrib>Teramoto, Reiji</creatorcontrib><creatorcontrib>Ramakrishnan, Chandrasekaran</creatorcontrib><creatorcontrib>Thangakani, A. Mary</creatorcontrib><creatorcontrib>Velmurugan, D.</creatorcontrib><creatorcontrib>Prathipati, Philip</creatorcontrib><creatorcontrib>Ito, Junichi</creatorcontrib><creatorcontrib>Tsuchiya, Yuko</creatorcontrib><creatorcontrib>Mizuguchi, Kenji</creatorcontrib><creatorcontrib>Honma, Teruki</creatorcontrib><creatorcontrib>Hirokawa, Takatsugu</creatorcontrib><creatorcontrib>Akiyama, Yutaka</creatorcontrib><creatorcontrib>Sekijima, Masakazu</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Scientific reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chiba, Shuntaro</au><au>Ikeda, Kazuyoshi</au><au>Ishida, Takashi</au><au>Gromiha, M. Michael</au><au>Taguchi, Y-h.</au><au>Iwadate, Mitsuo</au><au>Umeyama, Hideaki</au><au>Hsin, Kun-Yi</au><au>Kitano, Hiroaki</au><au>Yamamoto, Kazuki</au><au>Sugaya, Nobuyoshi</au><au>Kato, Koya</au><au>Okuno, Tatsuya</au><au>Chikenji, George</au><au>Mochizuki, Masahiro</au><au>Yasuo, Nobuaki</au><au>Yoshino, Ryunosuke</au><au>Yanagisawa, Keisuke</au><au>Ban, Tomohiro</au><au>Teramoto, Reiji</au><au>Ramakrishnan, Chandrasekaran</au><au>Thangakani, A. Mary</au><au>Velmurugan, D.</au><au>Prathipati, Philip</au><au>Ito, Junichi</au><au>Tsuchiya, Yuko</au><au>Mizuguchi, Kenji</au><au>Honma, Teruki</au><au>Hirokawa, Takatsugu</au><au>Akiyama, Yutaka</au><au>Sekijima, Masakazu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target</atitle><jtitle>Scientific reports</jtitle><stitle>Sci Rep</stitle><addtitle>Sci Rep</addtitle><date>2015-11-26</date><risdate>2015</risdate><volume>5</volume><issue>1</issue><spage>17209</spage><epage>17209</epage><pages>17209-17209</pages><artnum>17209</artnum><issn>2045-2322</issn><eissn>2045-2322</eissn><abstract>A search of broader range of chemical space is important for drug discovery. Different methods of computer-aided drug discovery (CADD) are known to propose compounds in different chemical spaces as hit molecules for the same target protein. This study aimed at using multiple CADD methods through open innovation to achieve a level of hit molecule diversity that is not achievable with any particular single method. We held a compound proposal contest, in which multiple research groups participated and predicted inhibitors of tyrosine-protein kinase Yes. This showed whether collective knowledge based on individual approaches helped to obtain hit compounds from a broad range of chemical space and whether the contest-based approach was effective.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>26607293</pmid><doi>10.1038/srep17209</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2045-2322 |
ispartof | Scientific reports, 2015-11, Vol.5 (1), p.17209-17209, Article 17209 |
issn | 2045-2322 2045-2322 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4660442 |
source | PubMed (Medline); MEDLINE; Nature Free; DOAJ Directory of Open Access Journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry; EZB Electronic Journals Library; Springer Nature OA Free Journals |
subjects | 631/114/2248 631/154/1435/2418 Drug Evaluation, Preclinical Humanities and Social Sciences Humans multidisciplinary Principal Component Analysis Protein Kinase Inhibitors - analysis Protein Kinase Inhibitors - pharmacology Proto-Oncogene Proteins c-yes - antagonists & inhibitors Proto-Oncogene Proteins c-yes - chemistry Reproducibility of Results Science src-Family Kinases - metabolism |
title | Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A31%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20potential%20inhibitors%20based%20on%20compound%20proposal%20contest:%20Tyrosine-protein%20kinase%20Yes%20as%20a%20target&rft.jtitle=Scientific%20reports&rft.au=Chiba,%20Shuntaro&rft.date=2015-11-26&rft.volume=5&rft.issue=1&rft.spage=17209&rft.epage=17209&rft.pages=17209-17209&rft.artnum=17209&rft.issn=2045-2322&rft.eissn=2045-2322&rft_id=info:doi/10.1038/srep17209&rft_dat=%3Cproquest_pubme%3E1738482024%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1738482024&rft_id=info:pmid/26607293&rfr_iscdi=true |